Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection

Lukas Paulsson-Habegger; Andrew K. Snabaitis; Stephen P. Wren

doi:10.1016/j.bmc.2021.116389

Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection

Lukas Paulsson-Habegger
, Andrew K. Snabaitis
, Stephen P. Wren

Kingston University

Research output: Contribution to journal › Article › peer-review

6 Downloads (Pure)

Original language	English
Article number	116389
Journal	Bioorganic and Medicinal Chemistry
Volume	48
Early online date	14 Sept 2021
DOIs	https://doi.org/10.1016/j.bmc.2021.116389
Publication status	Published - 15 Oct 2021

Keywords

Chemistry

Access to Document

10.1016/j.bmc.2021.116389

Wren-S-49936-AAMAccepted author manuscript, 280 KBLicence: CC BY-NC-ND

https://doi.org/10.1016/j.bmc.2021.116389

Cite this

@article{acc6340764f94cbca5bbdca967e9556e,

title = "Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection",

keywords = "Chemistry",

author = "Lukas Paulsson-Habegger and Snabaitis, \{Andrew K.\} and Wren, \{Stephen P.\}",

year = "2021",

month = oct,

day = "15",

doi = "10.1016/j.bmc.2021.116389",

language = "English",

volume = "48",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection

AU - Paulsson-Habegger, Lukas

AU - Snabaitis, Andrew K.

AU - Wren, Stephen P.

PY - 2021/10/15

Y1 - 2021/10/15

KW - Chemistry

UR - https://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry

U2 - 10.1016/j.bmc.2021.116389

DO - 10.1016/j.bmc.2021.116389

M3 - Article

SN - 0968-0896

VL - 48

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

M1 - 116389

ER -

Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection

Keywords

Access to Document

Other files and links

Cite this